Association between components of the insulin-like growth factor system and epithelial ovarian cancer risk

被引:28
作者
Dal Maso, L
Augustin, LSA
Franceschi, S
Talamini, R
Polesel, J
Kendall, CWC
Jenkins, DJA
Vidgen, E
La Vecchia, C
机构
[1] IRCCS, Serv Epidemiol & Biostat, Ctr Riferimento Oncol, I-33081 Aviano, Italy
[2] Univ Milan, Ist Ric Farmacol Mario Negri, Milan, Italy
[3] Univ Milan, Ist Stat Med & Biometria, I-20122 Milan, Italy
[4] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada
[5] St Michaels Hosp, Clin Nutr & Risk Modificat Ctr, Toronto, ON M5B 1W8, Canada
[6] Int Agcy Res Canc, F-69372 Lyon, France
关键词
ovarian cancer; IGF-I; IGFBP-1; IGFBP-3; case-control study;
D O I
10.1159/000081322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Components of the insulin-like growth factor (IGF) system have been associated with several cancers, but very few studies are available for ovarian cancer. Methods: A case-control study conducted between 1999 and 2003 in Italy, including a total of 59 women with incident, histologically confirmed ovarian cancer and 108 controls admitted to the same hospital network as cases, for acute non-neoplastic diseases. All subjects were interviewed using a validated questionnaire. Results: After adjustment for potential confounders, the multivariate odds ratios for the highest versus the lowest tertile of various IGF components were 0.6 (95% confidence interval, CI: 0.2-1.4) for free IGF-I, 0.4 (CI:0.1-1.5) for total IGF-I, 2.6 (CI:0.9-6.9) for IGF-binding protein (IGFBP)-1, and 0.2 (CI:0.0-0.6) for IGFBP-3. Conclusions: This study suggests a protective role of IGFBP-3 and a positive association of IGFBP-1 with ovarian cancer. The complex role of the IGF system in ovarian carcinogenesis deserves further clarification. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 38 条
[1]   Glycemic index in chronic disease: a review [J].
Augustin, LS ;
Franceschi, S ;
Jenkins, DJA ;
Kendall, CWC ;
La Vecchia, C .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2002, 56 (11) :1049-1071
[2]   Association between components of the insulin-like growth factor system and endometrial cancer risk [J].
Augustin, LSA ;
Dal Maso, L ;
Franceschi, S ;
Talamini, R ;
Kendall, CWC ;
Jenkins, DJA ;
Vidgen, E ;
La Vecchia, C .
ONCOLOGY, 2004, 67 (01) :54-59
[3]   Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy [J].
Augustin, LSA ;
Polesel, J ;
Bosetti, C ;
Kendall, CWC ;
La Vecchia, C ;
Parpinel, M ;
Conti, E ;
Montella, M ;
Franceschi, S ;
Jenkins, DJA ;
Dal Maso, L .
ANNALS OF ONCOLOGY, 2003, 14 (01) :78-84
[4]   IDENTIFICATION OF INSULIN AND INSULIN-LIKE GROWTH-FACTOR-I (IGF I) RECEPTORS IN OVARIAN-CANCER TISSUE [J].
BECK, EP ;
RUSSO, P ;
GLIOZZO, B ;
JAEGER, W ;
PAPA, V ;
WILDT, L ;
PEZZINO, V ;
LANG, N .
GYNECOLOGIC ONCOLOGY, 1994, 53 (02) :196-201
[5]   Nutrient intake and ovarian cancer: an Italian case-control study [J].
Bidoli, E ;
La Vecchia, C ;
Montella, M ;
Dal Maso, L ;
Conti, E ;
Negri, E ;
Scarabelli, C ;
Carbone, A ;
Decarli, A ;
Franceschi, S .
CANCER CAUSES & CONTROL, 2002, 13 (03) :255-261
[6]   PURIFIED PREPARATIONS OF THE AMNIOTIC FLUID-DERIVED INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN CONTAIN MULTIMERIC FORMS THAT ARE BIOLOGICALLY-ACTIVE [J].
BUSBY, WH ;
HOSSENLOPP, P ;
BINOUX, M ;
CLEMMONS, DR .
ENDOCRINOLOGY, 1989, 125 (02) :773-777
[7]   Reproductive and hormonal factors and ovarian cancer [J].
Chiaffarino, F ;
Pelucchi, C ;
Parazzini, F ;
Negri, E ;
Franceschi, S ;
Talamini, R ;
Conti, E ;
Montella, M ;
La Vecchia, C .
ANNALS OF ONCOLOGY, 2001, 12 (03) :337-341
[8]   Body size indices at different ages and epithelial ovarian cancer risk [J].
Dal Maso, L ;
Franceschi, S ;
Negri, E ;
Conti, E ;
Montella, M ;
Vaccarella, S ;
Canzonieri, V ;
Parazzini, F ;
La Vecchia, C .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (13) :1769-1774
[9]   AN INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING-PROTEIN ENHANCES THE BIOLOGIC RESPONSE TO IGF-I [J].
ELGIN, RG ;
BUSBY, WH ;
CLEMMONS, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3254-3258
[10]   Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: Correlation with cancer antigen 125 and tumor-associated trypsin inhibitor [J].
Flyvbjerg, A ;
Mogensen, O ;
Mogensen, B ;
Nielsen, OS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2308-2313